Performance Comparison of Microfluidic and Immunomagnetic Platforms for Pancreatic CTC Enrichment
November 15, 2025
Brand Name :
Gadoxetic Acid, Eovist
Synonyms :
gadoxetate
Class :
Nonionic/ High Osmolality, magnetic resonance imaging contrast media
Dosage Forms & Strengths Â
Injectable solution Â
0.25 mol/L Â
0.025 mmol/kg IV
Do not exceed the infusion rate 10 mL/15 sec
Adverse drug reactions Â
Frequency Defined Â
1-10% Â
Headache (1%) Â
Dizziness (1%) Â
Nausea (1%) Â
Back pain (1%) Â
Flushing sensation (1%) Â
<1% Â
Akathisia Â
Chills Â
Dysgeusia Â
Altered sense of smell Â
Fatigue Â
Asthenia Â
Hyperhidrosis Â
Increased serum bilirubin Â
Increased blood pressure Â
Chest pain Â
Dyspnea Â
 Â
Pregnancy warnings:    Â
Pregnancy Category: C Â
Lactation: Â
Excreted into human milk is unknown Â
Pregnancy Categories:       Â
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.  Â
Category B: there was no evidence of risk to the fetus in animal studies, and there were no enough studies on pregnant women. Â
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.   Â
Category D: adequate data available with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.   Â
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.   Â
Category N: There is no data available for the drug under this category Â
 Â
Patient Information Leaflet   Â
Generic Name: gadoxetate   Â
Why do we use gadoxetate? Â
gadoxetate is a magnetic resonance imaging contrast media used for MRI of Liver Lesions.Â